Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92


An internationally generalizable risk index for mortality after one year of antiretroviral therapy.

Tate JP, Justice AC, Hughes MD, Bonnet F, Reiss P, Mocroft A, Nattermann J, Lampe FC, Bucher HC, Sterling TR, Crane HM, Kitahata MM, May M, Sterne JA.

AIDS. 2013 Feb 20;27(4):563-72. doi: 10.1097/QAD.0b013e32835b8c7f.


Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis.

Justice AC, Modur SP, Tate JP, Althoff KN, Jacobson LP, Gebo KA, Kitahata MM, Horberg MA, Brooks JT, Buchacz K, Rourke SB, Rachlis A, Napravnik S, Eron J, Willig JH, Moore R, Kirk GD, Bosch R, Rodriguez B, Hogg RS, Thorne J, Goedert JJ, Klein M, Gill J, Deeks S, Sterling TR, Anastos K, Gange SJ; NA-ACCORD and VACS Project Teams.

J Acquir Immune Defic Syndr. 2013 Feb 1;62(2):149-63. doi: 10.1097/QAI.0b013e31827df36c.


Gender-Related Risk Factors Improve Mortality Predictive Ability of VACS Index Among HIV-Infected Women.

Cohen MH, Hotton AL, Hershow RC, Levine A, Bacchetti P, Golub ET, Anastos K, Young M, Gustafson D, Weber KM.

J Acquir Immune Defic Syndr. 2015 Dec 15;70(5):538-44. doi: 10.1097/QAI.0000000000000795.


Towards a combined prognostic index for survival in HIV infection: the role of 'non-HIV' biomarkers.

Justice AC, McGinnis KA, Skanderson M, Chang CC, Gibert CL, Goetz MB, Rimland D, Rodriguez-Barradas MC, Oursler KK, Brown ST, Braithwaite RS, May M, Covinsky KE, Roberts MS, Fultz SL, Bryant KJ; VACS Project Team.

HIV Med. 2010 Feb;11(2):143-51. doi: 10.1111/j.1468-1293.2009.00757.x. Epub 2009 Sep 14.


HIV infection, antiretroviral therapy initiation and longitudinal changes in biomarkers of organ function.

So-Armah KA, Chang J, Alcorn C, Lo Re V, Baker JV, Tracy R, Butt AA, Agan BK, Rimland D, Gibert CL, Goetz MB, Oursler KK, Rodriguez-Barradas MC, Kuller LH, Brown ST, Stein JH, Skanderson M, Justice AC, Freiberg MS.

Curr HIV Res. 2014;12(1):50-9.


Baseline, Time-Updated, and Cumulative HIV Care Metrics for Predicting Acute Myocardial Infarction and All-Cause Mortality.

Salinas JL, Rentsch C, Marconi VC, Tate J, Budoff M, Butt AA, Freiberg MS, Gibert CL, Goetz MB, Leaf D, Rodriguez-Barradas MC, Justice AC, Rimland D.

Clin Infect Dis. 2016 Dec 1;63(11):1423-1430. Epub 2016 Aug 18.


Elevated AST-to-platelet ratio index is associated with increased all-cause mortality among HIV-infected adults in Zambia.

Vinikoor MJ, Sinkala E, Mweemba A, Zanolini A, Mulenga L, Sikazwe I, Fried MW, Eron JJ, Wandeler G, Chi BH.

Liver Int. 2015 Jul;35(7):1886-92. doi: 10.1111/liv.12780. Epub 2015 Jan 22.


Sex disparities in overall burden of disease among HIV-infected individuals in the Veterans Affairs healthcare system.

Blackstock OJ, Tate JP, Akgün KM, Crystal S, Duggal M, Edelman EJ, Gibert CL, Gordon KS, Rimland D, Rodriguez-Barradas MC, Wang EA, Fiellin DA, Justice AC.

J Gen Intern Med. 2013 Jul;28 Suppl 2:S577-82. doi: 10.1007/s11606-013-2346-z.


Cohort profile: Antiretroviral Therapy Cohort Collaboration (ART-CC).

May MT, Ingle SM, Costagliola D, Justice AC, de Wolf F, Cavassini M, D'Arminio Monforte A, Casabona J, Hogg RS, Mocroft A, Lampe FC, Dabis F, Fätkenheuer G, Sterling TR, del Amo J, Gill MJ, Crane HM, Saag MS, Guest J, Brodt HR, Sterne JA; Antiretroviral Cohort Collaboration.

Int J Epidemiol. 2014 Jun;43(3):691-702. doi: 10.1093/ije/dyt010. Epub 2013 Apr 18.


Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV?

Justice AC, Freiberg MS, Tracy R, Kuller L, Tate JP, Goetz MB, Fiellin DA, Vanasse GJ, Butt AA, Rodriguez-Barradas MC, Gibert C, Oursler KA, Deeks SG, Bryant K; VACS Project Team.

Clin Infect Dis. 2012 Apr;54(7):984-94. doi: 10.1093/cid/cir989. Epub 2012 Feb 15.


The VACS index accurately predicts mortality and treatment response among multi-drug resistant HIV infected patients participating in the options in management with antiretrovirals (OPTIMA) study.

Brown ST, Tate JP, Kyriakides TC, Kirkwood KA, Holodniy M, Goulet JL, Angus BJ, Cameron DW, Justice AC; OPTIMA Team.

PLoS One. 2014 Mar 25;9(3):e92606. doi: 10.1371/journal.pone.0092606. eCollection 2014.


The VACS index predicts mortality in a young, healthy HIV population starting highly active antiretroviral therapy.

Bebu I, Tate J, Rimland D, Mesner O, Macalino GE, Ganesan A, Okulicz JF, Bavaro M, Weintrob AC, Justice AC, Agan BK; Infectious Disease Clinical Research Program HIV Working Group.

J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):226-30. doi: 10.1097/QAI.0000000000000045.


The veterans aging cohort study index is associated with concurrent risk for neurocognitive impairment.

Marquine MJ, Umlauf A, Rooney AS, Fazeli PL, Gouaux BD, Paul Woods S, Letendre SL, Ellis RJ, Grant I, Moore DJ; HIV Neurobehavioral Research Program (HNRP) Group.

J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):190-7. doi: 10.1097/QAI.0000000000000008.


Sex differences in overall and cause-specific mortality among HIV-infected adults on antiretroviral therapy in Europe, Canada and the US.

Antiretroviral Therapy Cohort Collaboration (ART-CC).

Antivir Ther. 2015;20(1):21-8. doi: 10.3851/IMP2768. Epub 2014 Mar 27.


Change in fibrosis score as a predictor of mortality among HIV-infected patients with viral hepatitis.

Jain MK, Seremba E, Bhore R, Dao D, Joshi R, Attar N, Yuan HJ, Lee WM.

AIDS Patient Care STDS. 2012 Feb;26(2):73-80. doi: 10.1089/apc.2011.0191. Epub 2012 Jan 12.


Association of the veterans aging cohort study index with exercise capacity in HIV-infected adults.

Oursler KK, Tate JP, Gill TM, Crothers K, Brown TT, Crystal S, Womack J, Leaf DA, Sorkin JD, Justice AC.

AIDS Res Hum Retroviruses. 2013 Sep;29(9):1218-23. doi: 10.1089/AID.2012.0388. Epub 2013 Jun 26.


When to Monitor CD4 Cell Count and HIV RNA to Reduce Mortality and AIDS-Defining Illness in Virologically Suppressed HIV-Positive Persons on Antiretroviral Therapy in High-Income Countries: A Prospective Observational Study.

Caniglia EC, Sabin C, Robins JM, Logan R, Cain LE, Abgrall S, Mugavero MJ, Hernandez-Diaz S, Meyer L, Seng R, Drozd DR, Seage GR 3rd, Bonnet F, Dabis F, Moore RR, Reiss P, van Sighem A, Mathews WC, Del Amo J, Moreno S, Deeks SG, Muga R, Boswell SL, Ferrer E, Eron JJ, Napravnik S, Jose S, Phillips A, Olson A, Justice AC, Tate JP, Bucher HC, Egger M, Touloumi G, Sterne JA, Costagliola D, Saag M, Hernán MA; Center for AIDS Research Network of Integrated Clinical Systems and the HIV-CAUSAL Collaboration.

J Acquir Immune Defic Syndr. 2016 Jun 1;72(2):214-21. doi: 10.1097/QAI.0000000000000956.


Differences in Response to Antiretroviral Therapy by Sex and Hepatitis C Infection Status.

Marcus JL, Leyden WA, Chao CR, Xu L, Quesenberry CP Jr, Tien PC, Klein DB, Towner WJ, Horberg MA, Silverberg MJ.

AIDS Patient Care STDS. 2015 Jul;29(7):370-8. doi: 10.1089/apc.2015.0040. Epub 2015 May 18.


Thirty-day postoperative mortality among individuals with HIV infection receiving antiretroviral therapy and procedure-matched, uninfected comparators.

King JT Jr, Perkal MF, Rosenthal RA, Gordon AJ, Crystal S, Rodriguez-Barradas MC, Butt AA, Gibert CL, Rimland D, Simberkoff MS, Justice AC.

JAMA Surg. 2015 Apr;150(4):343-51. doi: 10.1001/jamasurg.2014.2257.


Insurability of HIV-positive people treated with antiretroviral therapy in Europe: collaborative analysis of HIV cohort studies.

Kaulich-Bartz J, Dam W, May MT, Lederberger B, Widmer U, Phillips AN, Grabar S, Mocroft A, Vilaro J, van Sighem A, Moreno S, Dabis F, Monforte AD, Teira R, Ingle SM, Sterne JA; Writing Committee for the Antiretroviral Therapy Cohort Collaboration.

AIDS. 2013 Jun 19;27(10):1641-55. doi: 10.1097/QAD.0b013e3283601199.

Supplemental Content

Support Center